IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winkler, B. S.
Right arrow Articles by Puro, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkler, B. S.
Right arrow Articles by Puro, D. G.
(Investigative Ophthalmology and Visual Science. 2000;41:3183-3190.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Energy Metabolism in Human Retinal Müller Cells

Barry S. Winkler1, Matthew J. Arnold1, Melissa A. Brassell1 and Donald G. Puro2

1 From the Eye Research Institute, Oakland University, Rochester, Michigan; and 2 Department of Ophthalmology, University of Michigan Medical School, Ann Arbor.

PURPOSE. To measure selected parameters of energy metabolism and adenosine triphosphate (ATP) production in passaged monolayer cultures of human retinal glial (Müller) cells to assess the effects of varying substrate and oxygen availability on the biochemistry and histologic integrity of these cells.

METHODS. Confluent Müller cell cultures were incubated for up to 4 hours at 37°C in a modified minimal essential medium (no serum) under aerobic or mitochondrial-inhibited conditions in the presence and absence of 5 mM glucose or in the presence of lactate, pyruvate, glutamate, or glutamine. Cellular ATP levels, lactic acid production, and 14CO2 production from labeled glucose or glutamate were measured along with an examination of cellular morphology. Immunohistochemistry with antibodies to glial cell–specific proteins was also performed. Cells were positive for vimentin, but negative for glial fibrillary acidic protein and glutamine synthetase.

RESULTS. Human Müller cells maintained ATP content aerobically at the same level for 4 hours in the presence and absence of glucose. ATP content was also maintained anaerobically at a value equal to that found aerobically, but only in the presence of glucose. ATP content in human Müller cells declined to a very low level when glycolysis was blocked by iodoacetate, and inclusion of lactate, pyruvate, glutamate, or glutamine did not restore the level of ATP. Aerobically, lactic acid production accounted for 99% of the total glucose used, whereas the oxidation of glucose by the mitochondria accounted for only 1%. When mitochondria were inhibited with antimycin A, there was only a modest (1.3-fold) increase in the rate of lactic acid production. No significant differences were found in the histologic appearance of the cells after mitochondrial blockade, but there was massive death of cells after inhibition of glycolysis with iodoacetate.

CONCLUSIONS. These results suggest that, in the presence of glucose and oxygen, cultured Müller cells obtain their ATP principally from glycolysis and have a low rate of oxygen consumption. This metabolic pattern may spare oxygen for retinal neurons, particularly in the inner nuclear and ganglion cell layers under normal physiological conditions. Furthermore, retinal Müller cells in culture are resistant to anoxia or absence of glucose, which provides a basis for understanding why Müller cells are less susceptible than neurons to ischemia or hypoglycemia.




This article has been cited by other articles:


Home page
IOVSHome page
C. B. Lupien, C. Bolduc, S. Landreville, and C. Salesse
Comparison between the Gene Expression Profile of Human Muller Cells and Two Spontaneous Muller Cell Lines
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5229 - 5242.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. E. van Eeden, L. B. G. Tee, S. Lukehurst, C.-M. Lai, E. P. Rakoczy, L. D. Beazley, and S. A. Dunlop
Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4638 - 4645.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
R. M. H. Diederen, C. A. Starnes, B. A. Berkowitz, and B. S. Winkler
Reexamining the hyperglycemic pseudohypoxia hypothesis of diabetic oculopathy.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2726 - 2731.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. W. Hein, W. Xu, and L. Kuo
Dilation of Retinal Arterioles in Response to Lactate: Role of Nitric Oxide, Guanylyl Cyclase, and ATP-Sensitive Potassium Channels
Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 693 - 699.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. Chidlow, J. P. M. Wood, M. Graham, and N. N. Osborne
Expression of monocarboxylate transporters in rat ocular tissues
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C416 - C428.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Arai-Gaun, N. Katai, T. Kikuchi, T. Kurokawa, K. Ohta, and N. Yoshimura
Heme Oxygenase-1 Induced in Muller Cells Plays a Protective Role in Retinal Ischemia-Reperfusion Injury in Rats
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4226 - 4232.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. L. Kusner, V. P. Sarthy, and S. Mohr
Nuclear Translocation of Glyceraldehyde-3-Phosphate Dehydrogenase: A Role in High Glucose-Induced Apoptosis in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1553 - 1561.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. P. M. Wood, G. Chidlow, M. Graham, and N. N. Osborne
Energy Substrate Requirements of Rat Retinal Pigmented Epithelial Cells in Culture: Relative Importance of Glucose, Amino Acids, and Monocarboxylates
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1272 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
R. J. Casson, G. Chidlow, J. P. M. Wood, and N. N. Osborne
The Effect of Hyperglycemia on Experimental Retinal Ischemia
Arch Ophthalmol, March 1, 2004; 122(3): 361 - 366.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. Rambhatla, C.-P. Chiu, R. D. Glickman, and C. Rowe-Rendleman
In Vitro Differentiation Capacity of Telomerase Immortalized Human RPE Cells
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1622 - 1630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology